(Q24201906)

1

0 references

Jonathan Ross

2

0 references

Daniele G Fuhrich

3

0 references

Nelcy Rodriguez-Malagon

4

0 references

Rui V Duarte

Cochrane Database of Systematic Reviews

5

0 references

publication date

31 January 2013

0 references

published in

0 references

cites work

What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection (POPI) trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

Polymicrobial etiology of acute pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

Chlamydial and gonococcal infections in women seeking pregnancy testing at family-planning clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

Epidemiology, pathogenesis and treatment of pelvic inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

Current concepts in managing pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

Prevalence of sexually transmitted infections among sexually active Jordanian females

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

Prevalence of Neisseria gonorrhoeae infection in young subjects attending community clinics in South London

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

What is endometritis and does it require treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

The rate of diagnosis and demography of pelvic inflammatory disease in general practice: England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

Recent developments in meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

European guideline for the management of pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285

inferred from DOI database lookup

7 January 2021

based on heuristic

The evolving epidemiology of chlamydial and gonococcal infections in response to control programs in Winnipeg, Canada

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010285